Pharmacy bookkeeping sits at a peculiar intersection: a largely GST-free dispensing operation running alongside a fully taxable retail business, with income streams from government subsidies, patient co-payments, and wholesaler rebate programmes. Understanding the GST treatment of each income type, the revenue recognition timing for PBS claims, and the inventory obligations around controlled substances is essential for any bookkeeper servicing a community pharmacy.
PBS Dispensing Revenue: Gross Recognition and GST Treatment
When a pharmacy dispenses a Pharmaceutical Benefits Scheme (PBS) medicine, two separate amounts are received: the patient co-payment (collected at point of dispensing) and the government subsidy (processed through Medicare and settled to the pharmacy's bank account typically within 10–14 days).
Under s.38-50 of the A New Tax System (Goods and Services Tax) Act 1999 (GST Act), the supply of a PBS-listed medicine is GST-free. This applies to both the co-payment component and the subsidy component — the entire dispensing is a single GST-free supply. The pharmacist does not charge GST to the patient and cannot claim input tax credits on the cost of the PBS medicines purchased specifically for dispensing.
The revenue figure must reflect the gross dispensing value — the subsidy plus the co-payment. A pharmacy that records only the co-payment cash collected at the counter is materially understating its revenue. The correct entry is:
- Debit: Medicare subsidy receivable (for the PBS subsidy pending settlement)
- Debit: Cash or card receipts (for the patient co-payment)
- Credit: PBS dispensing revenue (gross amount — GST-free)
When the Medicare settlement arrives in the bank, it is applied against the subsidy receivable. At month end, review the outstanding subsidy receivable for claims submitted but not yet settled — this is a normal debtor balance, not a contingency.
Non-PBS products dispensed on private prescriptions, and all over-the-counter products in the retail area (vitamins, cosmetics, sunscreens, non-PBS OTC medicines), are standard taxable supplies at 10% GST. The critical distinction is whether a product appears on the PBS Schedule — if it does not, or if it is being supplied outside PBS conditions, GST applies.
Schedule 8 Controlled Substances: Inventory Reconciliation
Pharmacies that dispense Schedule 8 controlled substances (morphine, oxycodone, methadone, and other restricted drugs) are subject to strict state drug legislation — for example, the Drugs, Poisons and Controlled Substances Act 1981 (Vic) and equivalent state Acts. These require a physical drug register recording each receipt and dispensing event, with running balances maintained for each Schedule 8 product.
From a bookkeeping perspective, Schedule 8 inventory must reconcile with the physical register. If the pharmacy purchased 500 tablets of a Schedule 8 opioid during the month, dispensed 420 per the register, and the physical count shows 75 remaining, there is a discrepancy of 5 tablets. Any shortfall requires investigation before the books are finalised — it is simultaneously a compliance issue (regulators will expect an explanation), an insurance issue (theft or diversion affects coverage), and a bookkeeping issue (an unexplained inventory shrinkage).
The bookkeeper's role is to ensure the drug purchases are correctly entered into the inventory system and that the closing inventory count (which the registered pharmacist must perform) reconciles to what the books show. Do not close a period with an unreconciled Schedule 8 variance.
Wholesaler Rebates: Assessable Income and Timing
Most Australian community pharmacies belong to a buying group or banner group (for example, Chemist Warehouse, TerryWhite Chemmart, or Sigma Healthcare's network) that negotiates volume-based rebates with pharmaceutical wholesalers such as Sigma, Australian Pharmaceutical Industries (API, now owned by Wesfarmers), or EBOS Group.
Wholesaler rebates are assessable income under s.6-5 ITAA 1997. They are not a reduction in the cost of goods — they are a separate income stream arising from the commercial arrangement with the wholesaler or buying group. This distinction matters for both gross profit reporting (COGS should reflect actual purchase costs) and tax treatment.
The timing question is whether to recognise rebates on an accrual basis (as the volume thresholds are met during the year) or on receipt (when the rebate payment or credit note is received). Under the accrual principle, if the pharmacy has met a volume threshold by year end and is contractually entitled to a rebate, that rebate is assessable in the year the entitlement arose — not when it is eventually paid or credited in the following year. Review the buying group agreement at year end and accrue any rebates earned but not yet received.
For GST purposes, rebates received from a wholesaler are consideration for a supply only if the pharmacy is providing something to the wholesaler in return (e.g., preferred supplier status, shelf placement, exclusivity). If the rebate is simply a volume discount with no reciprocal obligation, it is treated as a reduction in consideration (not a separate taxable supply) and no GST adjustment entry should be made. If the arrangement does involve reciprocal services, a GST adjustment may be required — check the agreement terms carefully.
Compounding Pharmacies: FBT on Product Taken by Pharmacist
Compounding pharmacies that prepare bespoke medications for individual patients use equipment, ingredients, and staff time. If the pharmacist proprietor or an employee takes compounded product for personal use (for example, a customised skincare cream prepared on the compounding bench), this is a fringe benefit under the Fringe Benefits Tax Assessment Act 1986 (FBTAA).
The benefit is classified as a property fringe benefit (tangible property provided by the employer to the employee). The taxable value is the cost of the ingredients and time used, or the arm's-length market value if the product would be sold to the public. Pharmacist proprietors who are also employees of their own company can create FBT obligations on personal use of compounding materials — a fact that is commonly overlooked in small compounding pharmacies.
Returns to Stock vs. Expired or Recalled Product
When a patient returns an unopened PBS medicine (for example, because their prescription changed), the pharmacy may be able to return it to usable stock. This is a stock adjustment, not a revenue reversal — the dispensing event is complete and the PBS claim has been lodged.
Expired or recalled product returned to the wholesaler generates a credit note from the wholesaler, not a revenue reversal. The credit note reduces the cost of goods purchased in the period it is received (or creates a creditor credit). The original dispensing revenue stands. If the product was already expensed (not held in inventory), the credit note is other income. If held in inventory at year end and then returned, reduce the inventory balance by the cost of the returned goods.
End-of-Period Checklist for Pharmacy Bookkeepers
- Reconcile PBS subsidy receivable to Medicare statements: confirm all claims submitted during the period have either settled or are outstanding at a reasonable age; investigate any items beyond 30 days
- Confirm all PBS dispensing revenue is coded as GST-free (s.38-50 GST Act); review the revenue split between GST-free dispensing and taxable retail/OTC sales
- Reconcile Schedule 8 inventory: purchases per the creditor ledger vs. closing physical count per the drug register; ensure any variances are investigated and documented before period close
- Review wholesaler rebate agreements: accrue rebates earned to date against volume thresholds; confirm the GST treatment (volume discount vs. consideration for a supply) and adjust accordingly
- Check for any compounding product taken personally by the pharmacist or employees: calculate FBT liability at the taxable value of property provided
- Process wholesaler credit notes: code to COGS reduction (if current period purchase) or other income (if prior period expensed); do not reverse original dispensing revenue
- Confirm non-PBS private dispensing and retail product sales are coded as taxable supplies with 10% GST applied